의료 시뮬레이션 시장 규모, 점유율, 동향 분석 리포트 : 제품·서비스별, 기술별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Medical Simulation Market Size, Share & Trends Analysis Report By Product & Services (Healthcare Simulation Software, Simulation Training Services), By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,272,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,662,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,443,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

의료 시뮬레이션 시장의 성장과 동향 :

세계의 의료 시뮬레이션 시장 규모는 2030년까지 41억 9,000만 달러에 달할 것으로 예측됩니다.

2025-2030년의 CAGR은 16.80%로 시장은 확대할 것으로 예측됩니다. 최근 기술 동향은 강화된 인공호흡기, 심장 보조 장비, 심초음파 기술 등 새로운 의료기기 및 첨단 기술의 사용이 증가함에 따라 고객 교육 및 사내 제품 개발에 시뮬레이션과 같은 고급 교육 솔루션에 대한 필요성이 증가하고 있습니다. 인증 기관과 규제기관은 파괴적인 신기술을 채택하기 전에 의사와 임상의가 교육을 받을 것을 강력히 권고하고 있습니다. 실제 환자를 대상으로 한 실습을 대체할 수는 없지만, 시뮬레이션 교육은 안전한 학습 조건을 제공합니다. 시뮬레이션 훈련은 환자를 위험에 빠뜨리지 않기 때문에 학생과 레지던트가 이 단계에서 실수를 저지르는 것은 학습 과정의 중요한 부분입니다.

의료 시뮬레이션 학습 관리 기술을 다루는 Education Management Solutions, LLC는 의료 교육용 COVID-19 비상 대응 워크플로우를 발표했으며, CAE Healthcare는 교육자를 지원하기 위한 무료 웨비나, SCE, 아웃리치 툴킷을 제공하여 교육자들을 지원하기 위해 노력해왔습니다. 이러한 요인으로 인해 팬데믹 기간 중 의료 시뮬레이션 서비스에 대한 수요가 증가했습니다.

시장 경쟁이 치열합니다. 가장 주목할 만한 시장 진출기업은 CAE, Laerdal Medical, 3D Systems, Simulab Corporation, Limbs &Things Ltd, Mentice AB, Simulaids, Gaumard Scientific Company, Surgical Science Sweden AB, Kyoto Kagaku Co., Ltd이며, 시장에 대한 제품 제공에 의해 상당한 점유율을 차지하고 있습니다. 시장 리더들은 더 큰 점유율을 확보하기 위해 광범위한 유통 시스템 구축과 M&A를 진행하고 있습니다. 예를 들어 2021년 1월 Gaumard Scientific은 소아 HAL을 위한 초음파 시스템과 소아 응급상황 시나리오 모듈을 발표했습니다.

의료 시뮬레이션 시장 보고서 하이라이트

• 헬스케어 해부학 모델은 2024년 전체 시장에서 제품 및 서비스 부문을 지배했습니다. 이러한 시뮬레이터는 제조 및 연구 산업에서 테스트를 수행하는 데 도움이 되는 것으로 입증되었기 때문입니다.
• 병원 최종사용자 분야는 예측 기간 중 가장 빠른 CAGR 16.6%로 성장할 것으로 예상됩니다. 성장 요인으로는 고급 학습으로의 점진적인 전환과 오류 최소화에 대한 관심 증가를 들 수 있습니다.
• 시술 리허설 기술은 가장 큰 기술 부문이 될 것으로 예상됩니다. 환자 안전에 대한 요구가 높아짐에 따라 의료사고가 증가함에 따라 시술 리허설 기술에 대한 수요가 증가할 것으로 예상됩니다.
• 아시아태평양은 헬스케어 IT 지출 증가와 빠르게 발전하는 헬스케어 인프라로 인해 향후 수년간 급격한 성장을 기록할 것으로 예상됩니다.
• Surgical Science는 2022년 2월 Mimic Technologies의 자회사로 임베디드되어 로봇 수술 분야에서 입지를 다졌습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향, 범위

• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석 툴
  • Porter's Five Forces 분석
  • PESTL 분석
• 테크놀러지의 개요
  • 가상현실(VR)과 증강현실(AR)
  • 인공지능(AI)
  • 게이미피케이션
  • 시뮬레이터 개발에서 다분야 어프로치의 활용
  • 3D 프린트
  • HCIT/EMR-EHR
• COVID-19팬데믹의 영향
• 지역 레벨의 제품 유형별 추정 최종사용자 수

제4장 의료 시뮬레이션 시장 : 제품·서비스 추정·동향 분석

• 의료 시뮬레이션 제품 및 서비스 시장 : 부문 대시보드
• 2024년과 2030년 제품 동향과 시장 점유율 분석
  • 헬스케어 해부 모델
  • 헬스케어 시뮬레이션 소프트웨어(웹기반 시뮬레이터 포함)
  • 시뮬레이션 트레이닝 서비스

제5장 의료 시뮬레이션 시장 : 기술 추정·동향 분석

• 의료 시뮬레이션 기술 시장 : 부문 대시보드
• 기술 동향과 시장 점유율 분석, 2024년과 2030년
  • 가상 환자 시뮬레이션
  • 3D 프린트
  • 절차 리허설 기술

제6장 의료 시뮬레이션 시장 : 최종 용도의 추정·동향 분석

• 의료 시뮬레이션 최종 용도 시장 : 부문 대시보드
• 2024년과 2030년 기기 움직임과 시장 점유율 분석
  • 병원
  • 조사
  • 학술기관
  • 군 조직

제7장 지역 전망

• 지역 전망
• 지역별 의료 시뮬레이션 시장 : 마켓플레이스의 주요포인트
• 북미
  • 북미 의료 시뮬레이션 시장의 추정과 예측, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 의료 시뮬레이션 시장의 추정과 예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 의료 시뮬레이션 시장의 추정과 예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 라틴아메리카의 의료 시뮬레이션 시장의 추정과 예측, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카 의료 시뮬레이션 시장의 추정과 예측,2018-2030
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 기업/경쟁 분류
• 기업 시장 현황 분석, 2024년
• 기업 개요/상장기업
  • CAE, Inc.(Madison Industries acquired CAE healthcare division in October 2023)
  • Laerdal Medical
  • 3D Systems, Inc.
  • Simulab Corporation
  • Limbs &Things Ltd
  • Simulaids
  • Kyoto Kagaku Co., Ltd
  • Gaumard Scientific
  • Mentice
  • Surgical Science Sweden AB
  • Intelligent Ultrasound
  • Operative Experience, Inc.
  • Cardionics, Inc.
  • VirtaMed AG
  • SYNBONE AG
  • IngMar Medical
  • TruCorp
  • KaVo Dental
  • Simendo
  • Haag-Streit
  • Symgery
  • HRV Simulation
  • Synaptive Medical
  • Inovus Limited

KSA

영문 목차

영문목차

Medical Simulation Market Growth & Trends:

The global medical simulation market size is expected to reach a value of USD 4.19 billion by 2030. The market is expected to expand at a CAGR of 16.80% from 2025 to 2030. With recent technological advancements, the use of new medical devices and advanced procedures, such as enhanced mechanical ventilation devices, cardiac assist devices, and intra-cardiac echocardiography technology, is increasing; which drives the need for advanced training solutions, such as simulation, for customer training and internal product development. Certification and regulatory agencies are strictly recommending that physicians and clinicians be trained before the adoption of new, disruptive technologies. Although hands-on learning with real patients cannot be replaced, simulation training offers safe learning conditions. Students and medical residents making mistakes in this phase is an important part of the learning process, as in simulation training patients are not put at risk.

Education Management Solutions, LLC- a company dealing in medical simulation learning management technology-released workflows that were COVID-19 contingency ready for healthcare education. CAE Healthcare responded to the pandemic by helping with a complimentary webinar, SCE, and outreach toolkit to assist educators. Such factors boosted the demand for medical simulation services during the pandemic.

The market is very competitive. The most notable market participants are CAE, Laerdal Medical, 3D Systems, Simulab Corporation, Limbs & Things Ltd, Mentice AB, Simulaids, Gaumard Scientific Company, Surgical Science Sweden AB, Kyoto Kagaku Co., Ltd and account for a considerable share owing to their product offerings to the market. Market leaders are involved in the establishment of extensive distribution systems as well as in mergers and acquisitions to capture a larger share of the market. For instance, in January 2021, Gaumard Scientific Company revealed its ultrasound system and pediatric emergency scenario modules for Pediatric HAL.

Medical Simulation Market Report Highlights:

• Healthcare anatomical model dominated the products and services segment of the overall market in 2024, as these simulators are proving to be beneficial in the manufacturing and research industry for conducting trials.
• The hospitals end-user segment is expected to expand at the fastest CAGR of 16.6% over the forecast period. Factors responsible for the growth are the gradual shift of focus on advanced learning and increasing focus on minimizing errors.
• Procedural rehearsal technology is expected to be the largest technology segment. The rising number of medical errors leading to increasing demand for patient safety is expected to boost the demand for procedure rehearsal technology.
• The Asia Pacific region is anticipated to register rapid growth in the forthcoming years owing to the growing healthcare IT spending and rapidly evolving healthcare infrastructure.
• In February 2022, Surgical Science joined Mimic Technologies, thus expanding its foothold in the robotic surgery segment.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Segment Definition
    • 1.1.1.1 Product & Services Segment
    • 1.1.1.2 Technology Segment
    • 1.1.1.3 End Use Segment
• 1.2 Regional Scope
  • 1.2.1 Estimates and Forecast Timeline
• 1.3 Objectives
  • 1.3.1 Objective - 1
  • 1.3.2 Objective - 2
  • 1.3.3 Objective - 3
• 1.4 Research Methodology
• 1.5 Information Procurement
  • 1.5.1 Purchased Database
  • 1.5.2 GVR's Internal Database
  • 1.5.3 Secondary Sources
  • 1.5.4 Primary Research
  • 1.5.5 Details of Primary Research
• 1.6 Information or Data Analysis
  • 1.6.1 Data Analysis Models
• 1.7 Market Formulation & Validation
• 1.8 Model Details
  • 1.8.1 Consensus-Based Estimates & Forecasting
    • 1.8.1.1 Commodity Flow Analysis (Model 1)
      • 1.8.1.1.1 Segment-Level Company Revenue Estimates: A Key Example
    • 1.8.1.2 Parent market Analysis
    • 1.8.1.3 Secondary reliable published data
    • 1.8.1.4 Top-Down market estimation
    • 1.8.1.5 Country-based segment share calculation
    • 1.8.1.6 Medical Simulation Market: CAGR Calculation
• 1.9 List of Secondary Sources
• 1.10 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Outlook
• 2.3 Competitive Scenario

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Dynamics
  • 3.1.1 Market Driver Analysis
    • 3.1.1.1 Growing emphasis on patient safety and outcomes
    • 3.1.1.2 Shortage of qualified healthcare professionals
    • 3.1.1.3 Rising use of simulation, with a growing demand for innovative and custom training approaches to prevent medical errors
    • 3.1.1.4 Limited access to patients for educational and clinical development purposes
  • 3.1.2 Market Restraint Analysis
    • 3.1.2.1 High cost of simulators and limited investment in simulation systems
    • 3.1.2.2 Inadequately designed medical simulation equipment
• 3.2 Business Environment Analysis Tools
  • 3.2.1 Porter's Five Forces Analysis
  • 3.2.2 PESTL Analysis
• 3.3 Technology Overview
  • 3.3.1 Virtual Reality (VR) and Augmented Reality (AR)
  • 3.3.2 Artificial Intelligence (AI)
  • 3.3.3 Gamification
  • 3.3.4 Use of Multidisciplinary Approach in the Development of Simulators
  • 3.3.5 3D Printing
  • 3.3.6 HCIT/EMR-EHR
• 3.4 Impact of COVID-19 Pandemic
• 3.5 Estimated Number of End Users Per Product Type, at Regional Level

Chapter 4 Medical Simulation Market: Product & Services Estimates & Trend Analysis

• 4.1 Medical Simulation Product & Services Market: Segment Dashboard
• 4.2 Product Movement & Market Share Analysis, 2024 & 2030
• 4.3 Global Medical Simulation Market, Market Estimates & Forecast, by Product & Services
  • 4.3.1 Healthcare Anatomical Models
    • 4.3.1.1 Healthcare anatomical models market, 2018 - 2030 (USD Million)
    • 4.3.1.2 Type 1
      • 4.3.1.2.1 Patient Simulators
        • 4.3.1.2.1.1 Patient simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.2.1.2 Adult
          • 4.3.1.2.1.2.1 Adult market, 2018 - 2030 (USD Million)
        • 4.3.1.2.1.3 Pediatrics and Baby Care
          • 4.3.1.2.1.3.1 Pediatrics and baby care market, 2018 - 2030 (USD Million)
      • 4.3.1.2.2 Task Trainers
    • 4.3.1.2.2.1Task trainers market, 2018 - 2030 (USD Million)
    • 4.3.1.3 By Fidelity Type
      • 4.3.1.3.1 Low-fidelity
        • 4.3.1.3.1.1 Low-fidelity market, 2018 - 2030 (USD Million)
      • 4.3.1.3.2 Medium-fidelity
        • 4.3.1.3.2.1 Medium-fidelity simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.3.3 High-fidelity
        • 4.3.1.3.3.1 High-fidelity simulators market, 2018 - 2030 (USD Million)
    • 4.3.1.4 Type 2
      • 4.3.1.4.1 Interventional/Surgical Simulators
        • 4.3.1.4.1.1 Interventional/surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.2 Laproscopic Surgical Simulators
          • 4.3.1.4.1.2.1 Laproscopic surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.3 Gynecology Simulators
          • 4.3.1.4.1.3.1 Gynecology simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.4 Cardiovascular Simulators
          • 4.3.1.4.1.4.1 Cardiovascular simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.5 Arthroscopic Surgical Simulators
          • 4.3.1.4.1.5.1 Arthroscopic surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.6 Spine Surgical Simulators
          • 4.3.1.4.1.6.1 Spine surgical simulators market, 2018 - 2030 (USD Million)
        • 4.3.1.4.1.7 Other Interventional/Surgical Simulators
          • 4.3.1.4.1.7.1 Other interventional/surgical simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.2 Endovascular Simulators
        • 4.3.1.4.2.1 Endovascular simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.3 Ultrasound Simulators
        • 4.3.1.6.3.1 Ultrasound simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.4 Dental Simulators
        • 4.3.1.4.4.1 Dental simulators market, 2018 - 2030 (USD Million)
      • 4.3.1.4.5 Eye Simulators
        • 4.3.1.4.5.1 Eye simulators market, 2018 - 2030 (USD Million)
  • 4.3.2 Healthcare Simulation Software (Inclusive of Web-Based Simulators)
    • 4.3.2.1 Healthcare simulation software market, 2018 - 2030 (USD Million)
  • 4.3.3 Simulation Training Services
    • 4.3.3.1 Simulation training services market, 2018 - 2030 (USD Million)

Chapter 5 Medical Simulation Market: Technology Estimates & Trend Analysis

• 5.1 Medical Simulation Technology Market: Segment Dashboard
• 5.2 Technology Movement & Market Share Analysis, 2024 & 2030
• 5.3 Global Medical Simulation Market, Market Estimates & Forecast, by Technology
  • 5.3.1 Virtual Patient Simulation
    • 5.3.1.1 Virtual patient simulation market, 2018 - 2030 (USD Million)
  • 5.3.2 3D Printing
    • 5.3.2.1 3D printing market, 2018 - 2030 (USD Million)
  • 5.3.3 Procedure Rehearsal Technology
    • 5.3.3.1 Procedure rehearsal technology market, 2018 - 2030 (USD Million)

Chapter 6 Medical Simulation Market: End Use Estimates & Trend Analysis

• 6.1 Medical Simulation End Use Market: Segment Dashboard
• 6.2 Instrument Movement & Market Share Analysis, 2024 & 2030
• 6.3 Global Medical Simulation Market, Market Estimates & Forecast, by End Use
  • 6.3.1 Hospitals
    • 6.3.1.1 Hospitals market, 2018 - 2030 (USD Million)
  • 6.3.2 Research
    • 6.3.2.1 Research market, 2018 - 2030 (USD Million)
    • 6.3.2.2 Medical Device Companies
      • 6.3.2.2.1 Medical device companies market, 2018 - 2030 (USD Million)
    • 6.3.2.3 Others
      • 6.3.2.3.1 Others market, 2018 - 2030 (USD Million)
  • 6.3.3 Academic Institutes
    • 6.3.3.1 Academic institutes market, 2018 - 2030 (USD Million)
  • 6.3.4 Military Organizations
    • 6.3.4.1 Military organizations, 2018 - 2030 (USD Million)

Chapter 7 Regional Outlook

• 7.1 Regional Outlook
• 7.2 Medical Simulation Market by Region: Key Marketplace Takeaway
• 7.3 North America
  • 7.3.1 North America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.3.2 U.S.
    • 7.3.2.1 Key country dynamics
    • 7.3.2.2 U.S. medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.3.2.3 Competitive scenario
    • 7.3.2.4 Regulatory scenario
  • 7.3.3 Canada
    • 7.3.3.1 Key country dynamics
    • 7.3.3.2 Canada medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.3.3.3 Competitive scenario
    • 7.3.3.4 Regulatory scenario
  • 7.3.4 Mexico
    • 7.3.4.1 Key country dynamics
    • 7.3.4.2 Mexico medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.3.4.3 Competitive scenario
    • 7.3.4.4 Regulatory scenario
• 7.4 Europe
  • 7.4.1 Europe Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.4.2 UK
    • 7.4.2.1 Key country dynamics
    • 7.4.2.2 UK medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2.3 Competitive scenario
    • 7.4.2.4 Regulatory scenario
  • 7.4.3 Germany
    • 7.4.3.1 Key country dynamics
    • 7.4.3.2 Germany medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3.3 Competitive scenario
    • 7.4.3.4 Regulatory scenario
  • 7.4.4 France
    • 7.4.4.1 Key country dynamics
    • 7.4.4.2 France medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4.3 Competitive scenario
    • 7.4.4.4 Regulatory scenario
  • 7.4.5 Italy
    • 7.4.5.1 Key country dynamics
    • 7.4.5.2 Italy medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5.3 Competitive scenario
    • 7.4.5.4 Regulatory scenario
  • 7.4.6 Spain
    • 7.4.6.1 Key country dynamics
    • 7.4.6.2 Spain medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6.3 Competitive scenario
    • 7.4.6.4 Regulatory and reimbursement scenario
  • 7.4.7 Denmark
    • 7.4.7.1 Key country dynamics
    • 7.4.7.2 Denmark medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7.3 Competitive scenario
    • 7.4.7.4 Regulatory and reimbursement scenario
  • 7.4.8 Sweden
    • 7.4.8.1 Key country dynamics
    • 7.4.8.2 Sweden medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8.3 Competitive scenario
    • 7.4.8.4 Regulatory scenario
  • 7.4.9 Norway
    • 7.4.9.1 Key country dynamics
    • 7.4.9.2 Norway medical simulation market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9.3 Competitive scenario
    • 7.4.9.4 Regulatory and reimbursement scenario
• 7.5 Asia Pacific
  • 7.5.1 Asia Pacific Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.5.2 Japan
    • 7.5.2.1 Key country dynamics
    • 7.5.2.2 Japan medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.2.3 Competitive scenario
    • 7.5.2.4 Regulatory scenario
  • 7.5.3 China
    • 7.5.3.1 Key country dynamics
    • 7.5.3.2 China medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.3.3 Competitive scenario
    • 7.5.3.4 Regulatory scenario
  • 7.5.4 India
    • 7.5.4.1 Key country dynamics
    • 7.5.4.2 India medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.4.3 Competitive scenario
    • 7.5.4.4 Regulatory scenario
  • 7.5.5 Australia
    • 7.5.5.1 Key country dynamics
    • 7.5.5.2 Australia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.5.3 Competitive scenario
    • 7.5.5.4 Regulatory scenario
  • 7.5.6 South Korea
    • 7.5.6.1 Key country dynamics
    • 7.5.6.2 South Korea medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.6.3 Competitive scenario
    • 7.5.6.4 Regulatory scenario
  • 7.5.7 Thailand
    • 7.5.7.1 Key country dynamics
    • 7.5.7.2 Thailand medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.5.7.3 Competitive scenario
    • 7.5.7.4 Regulatory scenario
• 7.6 Latin America
  • 7.6.1 Latin America Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.6.2 Brazil
    • 7.6.2.1 Key country dynamics
    • 7.6.2.2 Brazil medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.6.2.3 Competitive scenario
    • 7.6.2.4 Regulatory scenario
  • 7.6.3 Argentina
    • 7.6.3.1 Key country dynamics
    • 7.6.3.2 Argentina medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.6.3.3 Competitive scenario
    • 7.6.3.4 Regulatory scenario
• 7.7 Middle East & Africa (MEA)
  • 7.7.1 MEA Medical Simulation Market Estimates and Forcast, 2018 - 2030 (USD Million)
  • 7.7.2 South Africa
    • 7.7.2.1 Key country dynamics
    • 7.7.2.2 South Africa medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.2.3 Competitive scenario
    • 7.7.2.4 Regulatory scenario
  • 7.7.3 Saudi Arabia
    • 7.7.3.1 Key country dynamics
    • 7.7.3.2 Saudi Arabia medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.3.3 Competitive scenario
    • 7.7.3.4 Regulatory scenario
  • 7.7.4 UAE
    • 7.7.4.1 Key country dynamics
    • 7.7.4.2 UAE medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.4.3 Competitive scenario
    • 7.7.4.4 Regulatory scenario
  • 7.7.5 Kuwait
    • 7.7.5.1 Key country dynamics
    • 7.7.5.2 Kuwait medical simulation market estimates and forcast, 2018 - 2030 (USD Million)
    • 7.7.5.3 Competitive scenario
    • 7.7.5.4 Regulatory scenario

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. CAE, Inc. (Madison Industries acquired CAE healthcare division in October 2023)
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Laerdal Medical
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. 3D Systems, Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Simulab Corporation
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Limbs & Things Ltd
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Simulaids
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Kyoto Kagaku Co., Ltd
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Gaumard Scientific
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Mentice
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Surgical Science Sweden AB
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Intelligent Ultrasound
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Operative Experience, Inc.
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Cardionics, Inc.
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives
  • 8.4.14. VirtaMed AG
    • 8.4.14.1. Company overview
    • 8.4.14.2. Financial performance
    • 8.4.14.3. Product benchmarking
    • 8.4.14.4. Strategic initiatives
  • 8.4.15. SYNBONE AG
    • 8.4.15.1. Company overview
    • 8.4.15.2. Financial performance
    • 8.4.15.3. Product benchmarking
    • 8.4.15.4. Strategic initiatives
  • 8.4.16. IngMar Medical
    • 8.4.16.1. Company overview
    • 8.4.16.2. Financial performance
    • 8.4.16.3. Product benchmarking
    • 8.4.16.4. Strategic initiatives
  • 8.4.17. TruCorp
    • 8.4.17.1. Company overview
    • 8.4.17.2. Financial performance
    • 8.4.17.3. Product benchmarking
    • 8.4.17.4. Strategic initiatives
  • 8.4.18. KaVo Dental
    • 8.4.18.1. Company overview
    • 8.4.18.2. Financial performance
    • 8.4.18.3. Product benchmarking
    • 8.4.18.4. Strategic initiatives
  • 8.4.19. Simendo
    • 8.4.19.1. Company overview
    • 8.4.19.2. Financial performance
    • 8.4.19.3. Product benchmarking
    • 8.4.19.4. Strategic initiatives
  • 8.4.20. Haag-Streit
    • 8.4.20.1. Company overview
    • 8.4.20.2. Financial performance
    • 8.4.20.3. Product benchmarking
    • 8.4.20.4. Strategic initiatives
  • 8.4.21. Symgery
    • 8.4.21.1. Company overview
    • 8.4.21.2. Financial performance
    • 8.4.21.3. Product benchmarking
    • 8.4.21.4. Strategic initiatives
  • 8.4.22. HRV Simulation
    • 8.4.22.1. Company overview
    • 8.4.22.2. Financial performance
    • 8.4.22.3. Product benchmarking
    • 8.4.22.4. Strategic initiatives
  • 8.4.23. Synaptive Medical
    • 8.4.23.1. Company overview
    • 8.4.23.2. Financial performance
    • 8.4.23.3. Product benchmarking
    • 8.4.23.4. Strategic initiatives
  • 8.4.24. Inovus Limited
    • 8.4.24.1. Company overview
    • 8.4.24.2. Financial performance
    • 8.4.24.3. Product benchmarking
    • 8.4.24.4. Strategic initiatives

관련자료